NDM-1-producing Acinetobacter baumannii from Algeria

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2214-2215

  Boulanger, Anne ^a   Naas, Thierry ^a   Fortineau, Nicolas ^a   Figueiredo, Samy ^a   Nordmann, Patrice ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; COLISTIN; EDETIC ACID; IMIPENEM; MEROPENEM; NETILMICIN; RIFAMPICIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ADULT; ALGERIA; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BLOOD CULTURE; CASE REPORT; DISEASE PREDISPOSITION; DISK DIFFUSION; EPSILOMETER TEST; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEAD INJURY; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NDM 1 GENE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TRAFFIC ACCIDENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ALGERIA; BETA-LACTAMASES; CONJUGATION, GENETIC; CRANIOCEREBRAL TRAUMA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ELECTROPORATION; HUMANS; INTENSIVE CARE; MALE; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 84858688258     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05653-11     Document Type: Letter

References (11)

1. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement M100-S20-U. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Espinal P, et al. 2011. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob. Agents Chemother. 55:5396-5398.
3. Kaase M, et al. 2011. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66:1260-1262.
4. Karthikeyan K, Thirunarayan MA, Krishnan P. 2010. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 65:2253-2254.
5. Naas T, et al. 2006. VEB-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg. Infect. Dis. 12:1214-1222.
6. Naas T, Nordmann P. 2009. Acinetobacter and β-lactams, p. 407-420. In Courvalin P, LeClercq R, Rice LB (ed), Antibiogram, 3rd ed. ASM Press, Washington, DC.
7. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemase- producing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798.
8. Nordmann P, Poirel L, Toleman MA, Walsh T. 2011. Does broadspectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J. Antimicrob. Chemother. 66:689-692.
9. Perez F, et al. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3471-3484. (Pubitemid 47519332)
10. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54:24-38.
11. Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836. (Pubitemid 44151282)